Kyung Bo Kim Selected Research

UK 101

9/2012

Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung Bo Kim Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 06/2007
10	Multiple Myeloma 11/2019 - 12/2011
3	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 12/2019
3	Macular Degeneration (Age-Related Maculopathy) 10/2021 - 01/2018
3	Geographic Atrophy 10/2021 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2017 - 12/2012
2	Blindness (Hysterical Blindness) 01/2021 - 01/2018
2	Cognitive Dysfunction 01/2020 - 12/2019
2	Melanoma (Melanoma, Malignant) 01/2017 - 04/2016
2	Hematologic Neoplasms (Hematological Malignancy) 01/2014 - 01/2013
1	Amyloid Plaque 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Disease Progression 12/2019
1	Carcinoid Tumor (Carcinoid) 11/2019
1	Residual Neoplasm 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Colonic Neoplasms (Colon Cancer) 08/2012
1	Hepatitis C 03/2012
1	Corneal Opacity 01/2012
1	Fibrosis (Cirrhosis) 01/2012
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2011
1	Hepatocellular Carcinoma (Hepatoma) 12/2010
1	Corneal Neovascularization 06/2007

Drug/Important Bio-Agent (IBA)

12	Proteasome InhibitorsIBA 12/2019 - 04/2008
11	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 04/2008
9	carfilzomibIBA 11/2019 - 08/2012
4	Peptides (Polypeptides)IBA 12/2021 - 08/2012
4	Bortezomib (Velcade)FDA Link 01/2019 - 12/2011
3	Retinaldehyde (Retinal)IBA 10/2021 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2010
3	Pharmaceutical PreparationsIBA 10/2016 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 04/2016 - 06/2007
2	Amyloid (Amyloid Fibrils)IBA 12/2021 - 12/2019
2	Complementary DNA (cDNA)IBA 10/2021 - 01/2021
2	UbiquitinIBA 11/2019 - 01/2012
2	Interleukin-4 (Interleukin 4)IBA 01/2017 - 04/2016
2	PolymersIBA 10/2016 - 11/2015
2	Small Interfering RNA (siRNA)IBA 04/2016 - 12/2012
2	epoxomicinIBA 05/2013 - 09/2012
2	Biological ProductsIBA 05/2013 - 04/2008
2	Catalytic DNA (Deoxyribozyme)IBA 03/2012 - 12/2010
1	NucleosidesIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020
1	Aspartic Acid (Aspartate)FDA Link 01/2020
1	EstersIBA 01/2020
1	NitrogenIBA 01/2020
1	ixazomibIBA 01/2019
1	Hydroxyl RadicalIBA 01/2019
1	InterferonsIBA 01/2018
1	InflammasomesIBA 01/2018
1	ElementsIBA 01/2018
1	Retroelements (Retrotransposon)IBA 01/2018
1	CyclodextrinsIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 04/2016
1	Caspase 3 (Caspase-3)IBA 04/2016
1	Caspase 9IBA 04/2016
1	Caspase 8 (Caspase-8)IBA 04/2016
1	MicellesIBA 11/2015
1	pyrazoleIBA 02/2015
1	Codon (Codons)IBA 01/2013
1	CarcinogensIBA 12/2012
1	Transcription Factors (Transcription Factor)IBA 12/2012
1	CC ChemokinesIBA 12/2012
1	Urethane (Ethyl Carbamate)IBA 12/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2012
1	NF-kappa B (NF-kB)IBA 12/2012
1	CytokinesIBA 12/2012
1	UK 101IBA 09/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2012
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2012
1	AlkaliesIBA 01/2012
1	DesminIBA 01/2012
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2012
1	Molecular Probes (Molecular Probe)IBA 12/2011
1	Subgenomic RNAIBA 12/2010
1	Dendrimers (Dendrons)IBA 12/2010
1	DioxinsIBA 04/2008
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2008
1	Angiogenesis InhibitorsIBA 06/2007
1	withaferin AIBA 06/2007
1	VimentinIBA 06/2007

Therapy/Procedure

6	Therapeutics 12/2021 - 04/2008